Statements of Cash Flows (USD $)	12 Months Ended
	Dec. 31, 2012	Dec. 31, 2011
Cash flows from operating activities:
Net (loss)	$ (1,872,903)	$ (1,872,903)
Adjustments to reconcile net loss to net cash used in operating activities
Depreciation	0	759
Fair value of stock opotions issued	914,600	18,188
Common Stock issued for services rendered	361,654	1,093.982
Prepaid expenses	82,633	(10,258)
Accounts payable and accrued expenses	66,864	63,420
Due from related party	(90,835)	(43,819)
Net cash used in operating activities:	(517,958)	(572,368)
Cash flows from investing activities:
Patent	(7,000)
Net cash (used in) investing activities:	(7,000)
Proceeds from issuance of common stock	460,000	150,000
Proceeds from exercise of warrants		118,446
Proceeds from exercise of options	7,500	58,000
Repayment of officer loan payable		(2,400)
Net cash provided by financing activities	467,500	324,046
Net increase/(decrease) in cash and cash equivalents	(57,458)	(248,322)
Cash and cash equivalents beginning of year	152,526	400,848
Cash and cash equivalents end of year	95,069	152,526
Non-cash financing activities
Common stock issued for payable		72,375
Deferred revenue		276,950
Prepayment of expenses through issuance of commom stock		82,633
Interest
Income taxes